Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Checkpoint Inhibitor-Related Colitis”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Testing effectiveness (Phase 2)Ended earlyNCT04768504
What this trial is testing

Tofacitinib for the Treatment of Refractory Immune-related Colitis from Checkpoint Inhibitor Therapy- TRICK Study

Who this might be right for
Immune-Mediated Colitis
Khashayar Esfahani 2
Not applicableStudy completedNCT06074874
What this trial is testing

Intestinal Biomarker Analysis After ECP for ICI Colitis

Who this might be right for
ColitisImmune Checkpoint Inhibitor-Related Colitis
University of Freiburg 20
Large-scale testing (Phase 3)Not Yet RecruitingNCT06337695
What this trial is testing

VERIFY: Vedolizumab for the Prevention of Immune Checkpoint Inhibitor Related Diarrhea or Colitis in Patients With Cancer

Who this might be right for
CancerCancer Metastatic
University of Calgary 298
Testing effectiveness (Phase 2)Active Not RecruitingNCT04407247
What this trial is testing

Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma

Who this might be right for
ColitisLung Non-Small Cell CarcinomaMalignant Genitourinary System Neoplasm+2 more
M.D. Anderson Cancer Center 47
Testing effectiveness (Phase 2)Looking for participantsNCT06807593
What this trial is testing

Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients

Who this might be right for
Cancer
M.D. Anderson Cancer Center 10
Testing effectiveness (Phase 2)WithdrawnNCT06521762
What this trial is testing

Etrasimod for Immune Checkpoint Inhibitor Diarrhea and Colitis

Who this might be right for
Immune Checkpoint Inhibitor-Related Diarrhea and Colitis
Yale University
Testing effectiveness (Phase 2)WithdrawnNCT05726396
What this trial is testing

A Pilot Study Testing the Safety and Feasibility of Restorative Microbiota Therapy (RMT) in Patients With Refractory Immune-checkpoint Inhibitor-related Colitis

Who this might be right for
Immune-related ColitisColitis
University of Minnesota
Testing effectiveness (Phase 2)Active Not RecruitingNCT04305145
What this trial is testing

Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVSkin Cancer Stage III+4 more
Massachusetts General Hospital 42
Not applicableStudy completedNCT05414552
What this trial is testing

ECP for Immune-related Adverse Events After Checkpoint Inhibitor Treatment

Who this might be right for
Immune Related Adverse EventsColitisHepatitis+1 more
University of Freiburg 11
Testing effectiveness (Phase 2)WithdrawnNCT06646016
What this trial is testing

EPIC- Extracorporeal Photopheresis (ECP) for Immune-related Colitis

Who this might be right for
Immune-related Colitis
Therakos LLC
Testing effectiveness (Phase 2)Looking for participantsNCT06841705
What this trial is testing

Early Vedolizumab as First-Line for Immune-Related Colitis Therapy Trial

Who this might be right for
Immune Checkpoint Inhibitor-Related Colitis
Shilpa Grover, MD, MPH 80